Abfab SRL
The score of Abfab shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +13 % Total assets +11 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Abfab's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 12 Jun 2026
- Year ended 31 Dec 2024filed on 10 Jun 2025
- Year ended 31 Dec 2023filed on 12 Jun 2024
- Year ended 31 Dec 2022filed on 22 Jun 2023
- Year ended 31 Dec 2021filed on 22 Jun 2022
Abfab's financial analysis
- Solvency99.4%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Abfab
Abfab's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0459.847.603
- VAT number
- BE0459847603
- Peppol
- Registered · 0208:0459847603 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 15 Jan 1997
- Registered office
- 1070 Anderlecht
- Latest accounts
- 2025 · filed on 12 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Abfab (SRL) has been based in Anderlecht since 1997, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 88,013 € and equity of €2.44m; its revenue is not published. Its solvency stands at 99.4%, above the median of its sector (37.8%).
Companies similar to Abfab
Companies in the same business, of comparable size and area, outside its group.
- De Witte - De Sutter Retail sale of pharmaceutical products Dendermonde · balance sheet €2.45m
- DE BIE T. Retail sale of pharmaceutical products Affligem · balance sheet €2.45m
- Tamiphar Retail sale of pharmaceutical products Lasne · balance sheet €2.46m
- Holsbeek Brecht - Sint -Lenaerts Retail sale of pharmaceutical products Brecht · balance sheet €2.44m
- Apotheek VAN DE Mierop - Mestdagh Retail sale of pharmaceutical products Beerse · balance sheet €2.44m
- Gobert Sophie Retail sale of pharmaceutical products Bruges · balance sheet €2.48m
- Pharmadefi Retail sale of pharmaceutical products Arlon · balance sheet €2.48m
- Extrapharm HUY Retail sale of pharmaceutical products Huy · balance sheet €2.43m
Frequently asked questions about Abfab
What is the revenue of Abfab?
Abfab files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Abfab?
In Belgium, the VAT number is the company number prefixed with BE: BE0459847603 for Abfab, if the company is VAT-registered. Its company number (CBE) is 0459.847.603.
Where is the registered office of Abfab?
According to the CBE register, the registered office of Abfab is in 1070 Anderlecht.
What is the equity of Abfab?
At the close of the 2025 financial year, the equity of Abfab amounts to 2,443,800 €, a solvency of 99.4% of total assets.
Who manages Abfab?
The register lists 1 active mandates at Abfab. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Abfab
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →